Tomer Kariv

Insider Reports History

Entity
Individual
Location
C/O Arno Therapeutics, Inc., 200 Route 31 North, Suite 104, Flemington, NJ
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tomer Kariv:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 10K May 30, 2024 Direct
Eloxx Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 2.86K Jan 30, 2023 Direct

Insider Reports Filed by Tomer Kariv

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. Jan 30, 2023 1 $0 4 Jan 31, 2023 Director
KROS Keros Therapeutics, Inc. Nov 29, 2022 6 -$1 4 Nov 30, 2022 Director, 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
KROS Keros Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director, 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. May 19, 2021 1 $0 4 May 20, 2021 Director
ELOX Eloxx Pharmaceuticals, Inc. May 13, 2021 4 $8M 4 May 17, 2021 Director
KROS Keros Therapeutics, Inc. Apr 7, 2020 0 $0 3/A Nov 30, 2022 Director, 10%+ Owner